Brief: EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis
19/07/2024 21:25
July 19 (Reuters) - Edap Tms SA EDAP.O :
* EDAP ANNOUNCES INTERIM RESULTS FROM PHASE 3 STUDY
EVALUATING
ROBOTIC HIFU FOR THE TREATMENT OF DEEP INFILTRATING
ENDOMETRIOSIS
* EDAP TMS SA: PRIMARY ENDPOINT OF REDUCED ACUTE PELVIC PAIN
IN
HIFU TREATMENT ARM COMPARED TO SHAM TREATMENT ARM WAS NOT MET
* EDAP TMS SA - PHASE 3 STUDY CONTINUES PER PROTOCOL
Source text for Eikon: ID:nGNXxlDvd
Further company coverage: EDAP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edap Tms SA
See all newsEdap Tms SA reports results for the quarter ended June 30 - Earnings Summary
FocalTherics slides after $40 million share sale
Brief: Focaltherics™ Announces Pricing Of Public Offering Of American Depositary Shares
Brief: Focaltherics™ Announces Proposed Public Offering Of American Depositary Shares
Edap Tms SA expected to post a loss of 20 cents a share - Earnings Preview